img

Global Mental Disorders Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mental Disorders Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Mental Disorders Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mental Disorders Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Children and Adolescents are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mental Disorders Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mental Disorders Drugs key manufacturers include Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb and Abbott Laboratories, etc. Johnson & Johnson, Pfizer, Eli Lilly are top 3 players and held % sales share in total in 2022.
Mental Disorders Drugs can be divided into Drugs for Schizophrenia, Antidepressants, Antipsychotics and Anxiolytics, etc. Drugs for Schizophrenia is the mainstream product in the market, accounting for % sales share globally in 2022.
Mental Disorders Drugs is widely used in various fields, such as Children, Adolescents and Adults,, etc. Children provides greatest supports to the Mental Disorders Drugs industry development. In 2022, global % sales of Mental Disorders Drugs went into Children filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mental Disorders Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Abbott Laboratories
Segment by Type
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Segment by Application


Children
Adolescents
Adults

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Mental Disorders Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mental Disorders Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mental Disorders Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mental Disorders Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mental Disorders Drugs introduction, etc. Mental Disorders Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Mental Disorders Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Mental Disorders Drugs Market Overview
1.1 Mental Disorders Drugs Product Overview
1.2 Mental Disorders Drugs Market Segment by Type
1.2.1 Drugs for Schizophrenia
1.2.2 Antidepressants
1.2.3 Antipsychotics
1.2.4 Anxiolytics
1.2.5 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.6 Drugs for Childhood and Adolescent Mental Illness
1.2.7 Drugs to Treat Cognitive Disorders
1.2.8 Sleep Disorders
1.2.9 Others
1.3 Global Mental Disorders Drugs Market Size by Type
1.3.1 Global Mental Disorders Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Mental Disorders Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Mental Disorders Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mental Disorders Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Mental Disorders Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Mental Disorders Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Mental Disorders Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Mental Disorders Drugs Sales Breakdown by Type (2018-2024)
2 Global Mental Disorders Drugs Market Competition by Company
2.1 Global Top Players by Mental Disorders Drugs Sales (2018-2024)
2.2 Global Top Players by Mental Disorders Drugs Revenue (2018-2024)
2.3 Global Top Players by Mental Disorders Drugs Price (2018-2024)
2.4 Global Top Manufacturers Mental Disorders Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mental Disorders Drugs Market Competitive Situation and Trends
2.5.1 Mental Disorders Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Mental Disorders Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Mental Disorders Drugs Market
2.8 Key Manufacturers Mental Disorders Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mental Disorders Drugs Status and Outlook by Region
3.1 Global Mental Disorders Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Mental Disorders Drugs Historic Market Size by Region
3.2.1 Global Mental Disorders Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Mental Disorders Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Mental Disorders Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Mental Disorders Drugs Forecasted Market Size by Region
3.3.1 Global Mental Disorders Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Mental Disorders Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Mental Disorders Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Mental Disorders Drugs by Application
4.1 Mental Disorders Drugs Market Segment by Application
4.1.1 Children
4.1.2 Adolescents
4.1.3 Adults
4.2 Global Mental Disorders Drugs Market Size by Application
4.2.1 Global Mental Disorders Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Mental Disorders Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Mental Disorders Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mental Disorders Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Mental Disorders Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Mental Disorders Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Mental Disorders Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Mental Disorders Drugs Sales Breakdown by Application (2018-2024)
5 North America Mental Disorders Drugs by Country
5.1 North America Mental Disorders Drugs Historic Market Size by Country
5.1.1 North America Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Mental Disorders Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Mental Disorders Drugs Sales in Value by Country (2018-2024)
5.2 North America Mental Disorders Drugs Forecasted Market Size by Country
5.2.1 North America Mental Disorders Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Mental Disorders Drugs Sales in Value by Country (2024-2034)
6 Europe Mental Disorders Drugs by Country
6.1 Europe Mental Disorders Drugs Historic Market Size by Country
6.1.1 Europe Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Mental Disorders Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Mental Disorders Drugs Sales in Value by Country (2018-2024)
6.2 Europe Mental Disorders Drugs Forecasted Market Size by Country
6.2.1 Europe Mental Disorders Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Mental Disorders Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Mental Disorders Drugs by Region
7.1 Asia-Pacific Mental Disorders Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Mental Disorders Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Mental Disorders Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Mental Disorders Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Mental Disorders Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Mental Disorders Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Mental Disorders Drugs Sales in Value by Region (2024-2034)
8 Latin America Mental Disorders Drugs by Country
8.1 Latin America Mental Disorders Drugs Historic Market Size by Country
8.1.1 Latin America Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Mental Disorders Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Mental Disorders Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Mental Disorders Drugs Forecasted Market Size by Country
8.2.1 Latin America Mental Disorders Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Mental Disorders Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Mental Disorders Drugs by Country
9.1 Middle East and Africa Mental Disorders Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Mental Disorders Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Mental Disorders Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Mental Disorders Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Mental Disorders Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Mental Disorders Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Mental Disorders Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Johnson & Johnson Mental Disorders Drugs Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Mental Disorders Drugs Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly Mental Disorders Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 GlaxoSmithKline
10.4.1 GlaxoSmithKline Company Information
10.4.2 GlaxoSmithKline Introduction and Business Overview
10.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GlaxoSmithKline Mental Disorders Drugs Products Offered
10.4.5 GlaxoSmithKline Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Mental Disorders Drugs Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bristol-Myers Squibb Mental Disorders Drugs Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Abbott Laboratories
10.7.1 Abbott Laboratories Company Information
10.7.2 Abbott Laboratories Introduction and Business Overview
10.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Abbott Laboratories Mental Disorders Drugs Products Offered
10.7.5 Abbott Laboratories Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mental Disorders Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mental Disorders Drugs Industrial Chain Analysis
11.4 Mental Disorders Drugs Market Dynamics
11.4.1 Mental Disorders Drugs Industry Trends
11.4.2 Mental Disorders Drugs Market Drivers
11.4.3 Mental Disorders Drugs Market Challenges
11.4.4 Mental Disorders Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mental Disorders Drugs Distributors
12.3 Mental Disorders Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Drugs for Schizophrenia
Table 2. Major Company of Antidepressants
Table 3. Major Company of Antipsychotics
Table 4. Major Company of Anxiolytics
Table 5. Major Company of Drugs for the Treatment of Substance and Alcohol Addiction
Table 6. Major Company of Drugs for Childhood and Adolescent Mental Illness
Table 7. Major Company of Drugs to Treat Cognitive Disorders
Table 8. Major Company of Sleep Disorders
Table 9. Major Company of Others
Table 10. Global Mental Disorders Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 11. Global Mental Disorders Drugs Sales by Type (2018-2024) & (K Units)
Table 12. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2018-2024)
Table 13. Global Mental Disorders Drugs Sales by Type (2018-2024) & (US& Million)
Table 14. Global Mental Disorders Drugs Market Share in Value by Type (2018-2024)
Table 15. Global Mental Disorders Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 16. Global Mental Disorders Drugs Sales by Type (2024-2034) & (K Units)
Table 17. Global Mental Disorders Drugs Sales Market Share in Volume by Type (2024-2034)
Table 18. Global Mental Disorders Drugs Sales by Type (2024-2034) & (US$ Million)
Table 19. Global Mental Disorders Drugs Sales Market Share in Value by Type (2024-2034)
Table 20. Global Mental Disorders Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 21. North America Mental Disorders Drugs Sales by Type (2018-2024) & (K Units)
Table 22. North America Mental Disorders Drugs Sales by Type (2018-2024) & (US$ Million)
Table 23. Europe Mental Disorders Drugs Sales (K Units) by Type (2018-2024)
Table 24. Europe Mental Disorders Drugs Sales by Type (2018-2024) & (US$ Million)
Table 25. Asia-Pacific Mental Disorders Drugs Sales (K Units) by Type (2018-2024)
Table 26. Asia-Pacific Mental Disorders Drugs Sales by Type (2018-2024) & (US$ Million)
Table 27. Latin America Mental Disorders Drugs Sales (K Units) by Type (2018-2024)
Table 28. Latin America Mental Disorders Drugs Sales by Type (2018-2024) & (US$ Million)
Table 29. Middle East and Africa Mental Disorders Drugs Sales (K Units) by Type (2018-2024)
Table 30. Middle East and Africa Mental Disorders Drugs Sales by Type (2018-2024) & (US$ Million)
Table 31. Global Mental Disorders Drugs Sales by Company (2018-2024) & (K Units)
Table 32. Global Mental Disorders Drugs Sales Share by Company (2018-2024)
Table 33. Global Mental Disorders Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 34. Global Mental Disorders Drugs Revenue Share by Company (2018-2024)
Table 35. Global Market Mental Disorders Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 36. Global Mental Disorders Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 37. Global Mental Disorders Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 38. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2022)
Table 39. Date of Key Manufacturers Enter into Mental Disorders Drugs Market
Table 40. Key Manufacturers Mental Disorders Drugs Product Type
Table 41. Mergers & Acquisitions, Expansion Plans
Table 42. Global Mental Disorders Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 43. Global Mental Disorders Drugs Sales by Region (2018-2024) & (K Units)
Table 44. Global Mental Disorders Drugs Sales Market Share in Volume by Region (2018-2024)
Table 45. Global Mental Disorders Drugs Sales by Region (2018-2024) & (US$ Million)
Table 46. Global Mental Disorders Drugs Sales Market Share in Value by Region (2018-2024)
Table 47. Global Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 48. Global Mental Disorders Drugs Sales by Region (2024-2034) & (K Units)
Table 49. Global Mental Disorders Drugs Sales Market Share in Volume by Region (2024-2034)
Table 50. Global Mental Disorders Drugs Sales by Region (2024-2034) & (US$ Million)
Table 51. Global Mental Disorders Drugs Sales Market Share in Value by Region (2024-2034)
Table 52. Global Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 53. Global Mental Disorders Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 54. Global Mental Disorders Drugs Sales by Application (2018-2024) & (K Units)
Table 55. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2018-2024)
Table 56. Global Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 57. Global Mental Disorders Drugs Sales Market Share in Value by Application (2018-2024)
Table 58. Global Mental Disorders Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 59. Global Mental Disorders Drugs Sales by Application (2024-2034) & (K Units)
Table 60. Global Mental Disorders Drugs Sales Market Share in Volume by Application (2024-2034)
Table 61. Global Mental Disorders Drugs Sales by Application (2024-2034) & (US$ Million)
Table 62. Global Mental Disorders Drugs Sales Market Share in Value by Application (2024-2034)
Table 63. Global Mental Disorders Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 64. North America Mental Disorders Drugs Sales by Application (2018-2024) (K Units)
Table 65. North America Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 66. Europe Mental Disorders Drugs Sales by Application (2018-2024) (K Units)
Table 67. Europe Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 68. Asia-Pacific Mental Disorders Drugs Sales by Application (2018-2024) (K Units)
Table 69. Asia-Pacific Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 70. Latin America Mental Disorders Drugs Sales by Application (2018-2024) (K Units)
Table 71. Latin America Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 72. Middle East and Africa Mental Disorders Drugs Sales by Application (2018-2024) (K Units)
Table 73. Middle East and Africa Mental Disorders Drugs Sales by Application (2018-2024) & (US$ Million)
Table 74. North America Mental Disorders Drugs Sales by Country (2018-2024) & (K Units)
Table 75. North America Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2024)
Table 76. North America Mental Disorders Drugs Sales by Country (2018-2024) & (US$ Million)
Table 77. North America Mental Disorders Drugs Sales Market Share in Value by Country (2018-2024)
Table 78. North America Mental Disorders Drugs Sales by Country (2024-2034) & (K Units)
Table 79. North America Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2034)
Table 80. North America Mental Disorders Drugs Sales by Country (2024-2034) & (US$ Million)
Table 81. North America Mental Disorders Drugs Sales Market Share in Value by Country (2024-2034)
Table 82. Europe Mental Disorders Drugs Sales by Country (2018-2024) & (K Units)
Table 83. Europe Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2024)
Table 84. Europe Mental Disorders Drugs Sales by Country (2018-2024) & (US$ Million)
Table 85. Europe Mental Disorders Drugs Sales Market Share in Value by Country (2018-2024)
Table 86. Europe Mental Disorders Drugs Sales by Country (2024-2034) & (K Units)
Table 87. Europe Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2034)
Table 88. Europe Mental Disorders Drugs Sales by Country (2024-2034) & (US$ Million)
Table 89. Europe Mental Disorders Drugs Sales Market Share in Value by Country (2024-2034)
Table 90. Asia-Pacific Mental Disorders Drugs Sales by Region (2018-2024) & (K Units)
Table 91. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Region (2018-2024)
Table 92. Asia-Pacific Mental Disorders Drugs Sales by Region (2018-2024) & (US$ Million)
Table 93. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Region (2018-2024)
Table 94. Asia-Pacific Mental Disorders Drugs Sales by Region (2024-2034) & (K Units)
Table 95. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Region (2024-2034)
Table 96. Asia-Pacific Mental Disorders Drugs Sales by Region (2024-2034) & (US$ Million)
Table 97. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Region (2024-2034)
Table 98. Latin America Mental Disorders Drugs Sales by Country (2018-2024) & (K Units)
Table 99. Latin America Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2024)
Table 100. Latin America Mental Disorders Drugs Sales by Country (2018-2024) & (US$ Million)
Table 101. Latin America Mental Disorders Drugs Sales Market Share in Value by Country (2018-2024)
Table 102. Latin America Mental Disorders Drugs Sales by Country (2024-2034) & (K Units)
Table 103. Latin America Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2034)
Table 104. Latin America Mental Disorders Drugs Sales by Country (2024-2034) & (US$ Million)
Table 105. Latin America Mental Disorders Drugs Sales Market Share in Value by Country (2024-2034)
Table 106. Middle East and Africa Mental Disorders Drugs Sales by Country (2018-2024) & (K Units)
Table 107. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Country (2018-2024)
Table 108. Middle East and Africa Mental Disorders Drugs Sales by Country (2018-2024) & (US$ Million)
Table 109. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Country (2018-2024)
Table 110. Middle East and Africa Mental Disorders Drugs Sales by Country (2024-2034) & (K Units)
Table 111. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Country (2024-2034)
Table 112. Middle East and Africa Mental Disorders Drugs Sales by Country (2024-2034) & (US$ Million)
Table 113. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Country (2024-2034)
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Johnson & Johnson Mental Disorders Drugs Product
Table 118. Johnson & Johnson Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Pfizer Mental Disorders Drugs Product
Table 123. Pfizer Recent Development
Table 124. Eli Lilly Company Information
Table 125. Eli Lilly Introduction and Business Overview
Table 126. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Eli Lilly Mental Disorders Drugs Product
Table 128. Eli Lilly Recent Development
Table 129. GlaxoSmithKline Company Information
Table 130. GlaxoSmithKline Introduction and Business Overview
Table 131. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. GlaxoSmithKline Mental Disorders Drugs Product
Table 133. GlaxoSmithKline Recent Development
Table 134. AstraZeneca Company Information
Table 135. AstraZeneca Introduction and Business Overview
Table 136. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. AstraZeneca Mental Disorders Drugs Product
Table 138. AstraZeneca Recent Development
Table 139. Bristol-Myers Squibb Company Information
Table 140. Bristol-Myers Squibb Introduction and Business Overview
Table 141. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Bristol-Myers Squibb Mental Disorders Drugs Product
Table 143. Bristol-Myers Squibb Recent Development
Table 144. Abbott Laboratories Company Information
Table 145. Abbott Laboratories Introduction and Business Overview
Table 146. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Abbott Laboratories Mental Disorders Drugs Product
Table 148. Abbott Laboratories Recent Development
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Mental Disorders Drugs Market Trends
Table 152. Mental Disorders Drugs Market Drivers
Table 153. Mental Disorders Drugs Market Challenges
Table 154. Mental Disorders Drugs Market Restraints
Table 155. Mental Disorders Drugs Distributors List
Table 156. Mental Disorders Drugs Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Mental Disorders Drugs Product Picture
Figure 2. Global Mental Disorders Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Mental Disorders Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Mental Disorders Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Drugs for Schizophrenia
Figure 6. Global Drugs for Schizophrenia Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Antidepressants
Figure 8. Global Antidepressants Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Antipsychotics
Figure 10. Global Antipsychotics Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Anxiolytics
Figure 12. Global Anxiolytics Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Drugs for the Treatment of Substance and Alcohol Addiction
Figure 14. Global Drugs for the Treatment of Substance and Alcohol Addiction Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Drugs for Childhood and Adolescent Mental Illness
Figure 16. Global Drugs for Childhood and Adolescent Mental Illness Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Drugs to Treat Cognitive Disorders
Figure 18. Global Drugs to Treat Cognitive Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Sleep Disorders
Figure 20. Global Sleep Disorders Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Product Picture of Others
Figure 22. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 23. Global Mental Disorders Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 24. Global Mental Disorders Drugs Sales Market Share by Type in 2022 & 2034
Figure 25. North America Mental Disorders Drugs Sales Market Share in Volume by Type in 2022
Figure 26. North America Mental Disorders Drugs Sales Market Share in Value by Type in 2022
Figure 27. Europe Mental Disorders Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Europe Mental Disorders Drugs Sales Market Share in Value by Type in 2022
Figure 29. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Type in 2022
Figure 31. Latin America Mental Disorders Drugs Sales Market Share in Volume by Type in 2022
Figure 32. Latin America Mental Disorders Drugs Sales Market Share in Value by Type in 2022
Figure 33. Middle East and Africa Mental Disorders Drugs Sales Market Share in Volume by Type in 2022
Figure 34. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Type in 2022
Figure 35. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorders Drugs Sales in 2022
Figure 36. The 5 and 10 Largest Manufacturers in the World: Market Share by Mental Disorders Drugs Revenue in 2022
Figure 37. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Product Picture of Children
Figure 39. Global Children Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Adolescents
Figure 41. Global Adolescents Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Product Picture of Adults
Figure 43. Global Adults Sales YoY Growth (2018-2034) & (K Units)
Figure 44. Global Mental Disorders Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 45. Global Mental Disorders Drugs Sales Market Share by Application in 2022 & 2034
Figure 46. North America Mental Disorders Drugs Sales Market Share in Volume by Application in 2022
Figure 47. North America Mental Disorders Drugs Sales Market Share in Value by Application in 2022
Figure 48. Europe Mental Disorders Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Europe Mental Disorders Drugs Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific Mental Disorders Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific Mental Disorders Drugs Sales Market Share in Value by Application in 2022
Figure 52. Latin America Mental Disorders Drugs Sales Market Share in Volume by Application in 2022
Figure 53. Latin America Mental Disorders Drugs Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa Mental Disorders Drugs Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. Mental Disorders Drugs Manufacturing Cost Structure
Figure 57. Mental Disorders Drugs Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries